Point-of-Care Testing Gains Recognition
The value of point-of-care testing is highlighted this week with an award for the developer of NACDS' Point-of-Care Testing Certificate program and an NACDS webinar on the topic.
The value of point-of-care testing is highlighted this week with an award for the developer of NACDS' Point-of-Care Testing Certificate program and an NACDS webinar on the topic.
Lawmakers' constituent newsletters and social media posts reflect the success of NACDS RxIMPACT Day on Capitol Hill on pressing issues—including the opioid abuse epidemic.
On the heels of last week’s record-setting advocacy day on the Hill, NACDS RxIMPACT just kept going--to the D’Youville School of Pharmacy in Buffalo, N.Y., for a Grassroots Training Program.
Record-setting NACDS RxIMPACT Day on Capitol Hill provides ideal venue for grassroots, political honors.
More than 450 community pharmacists, pharmacy executives, student pharmacists, and national and state association allies and others—representing 50 states—convened in Washington, D.C. March 7-8 for the 10th annual NACDS RxIMPACT Day on Capitol Hill.
NACDS RxIMPACT participants documented their journey advocating for pharmacy in D.C. today.
More than 400 NACDS RxIMPACT Day on Capitol Hill pharmacy advocates are set to reach 100 percent of all House and Senate offices today for the first time in the event's history.
NACDS, member companies and other stakeholders met with South Carolina legislators on key opioid issues in S.C.
NACDS underscored strategies to combat the opioid epidemic this week to Senate and House Committees.
At the invitation of The White House, NACDS participated in today’s White House Opioid Summit that featured the involvement of President Donald Trump, First Lady Melania Trump, and members of the President’s Cabinet.